Treatment abandonment and refusal among children with central nervous system tumors in Jordan

被引:3
|
作者
Amayiri, Nisreen [1 ]
Bouffet, Eric [2 ]
机构
[1] King Hussein Canc Ctr, Div Pediat Hematol Oncol, 202 Queen Rania Al Abdullah St,POB 1269, Amman 11941, Jordan
[2] Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada
关键词
abandonment; LMIC; pediatric CNS tumors; ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER;
D O I
10.1002/pbc.29054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Treatment abandonment and refusal are reported to contribute significantly to poor survival of children with cancer in low- and middle-income countries. We aimed to assess this phenomenon among children diagnosed with central nervous system (CNS) tumors in Jordan. Methods We retrospectively reviewed the medical charts of children <18 years diagnosed with CNS tumors (2010-2020). Patients who abandoned or refused part of treatment were reviewed for their clinical characteristics, social circumstances, and possible reasons. We excluded patients referred for second opinion, radiotherapy only, or who traveled abroad for treatment. Results Four hundred seventy-three Jordanian children were identified; 12 families (2.5%) abandoned treatment, and 15 refused part of therapy (3%). Most patients were females (67%) and most had good or moderate performance status (89%). Most families (93%) lived within 2 hours from King Hussein Cancer Center. Most parents were university graduates (71%) and all fathers were employed, while 71% of mothers were housewives. The most common reasons to abandon or refuse therapy were treatment intensity in view of poor tumor outcome or bad quality of life, conflicting recommendations from other health care providers, "personal beliefs" against chemotherapy, and preference to use alternative medicine. Conclusions Treatment abandonment and refusal in Jordanian children with CNS tumors is low. Universal cancer insurance, high level of education in the country, centralized cancer care in one institution, and the twinning program likely contributed to our low incidence. Improving knowledge on CNS tumors and better community rehabilitation and supportive services may help further decrease the abandonment and treatment refusal rate.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data
    Crotty, Erin E. E.
    Wilson, Ashley L. L.
    Davidson, Tom
    Tahiri, Sophia
    Gust, Juliane
    Griesinger, Andrea M. M.
    Venkataraman, Sujatha
    Park, Julie R. R.
    Mueller, Sabine
    Rood, Brian R. R.
    Hwang, Eugene I. I.
    Wang, Leo D. D.
    Vitanza, Nicholas A. A.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (08) : 847 - 855
  • [22] Impact of central nervous system-directed treatment on competence and adjustment among children in early cancer survivorship
    Winning, Adrien M.
    Moscato, Emily L.
    Lehmann, Vicky
    Keim, Madelaine C.
    Rausch, Joseph R.
    Lipak, Keagan G.
    Himelhoch, Alexandra C.
    Murphy, Lexa K.
    Prussien, Kemar, V
    Olshefski, Randal S.
    Vannatta, Kathryn
    Compas, Bruce E.
    Gerhardt, Cynthia A.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [23] Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors
    Desandes, Emmanuel
    Guissou, Sandra
    Chastagner, Pascal
    Lacour, Brigitte
    NEURO-ONCOLOGY, 2014, 16 (07) : 975 - 983
  • [24] A Review of Secondary Central Nervous System Tumors After Treatment of a Primary Pediatric Malignancy
    Marks, Asher M.
    Packer, Roger J.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2012, 19 (01) : 43 - 48
  • [25] Development of dyslipidemia in patients after complex treatment of central nervous system tumors in childhood
    Novikova, A. I.
    Pavlova, M. G.
    Potemkina, N. A.
    Fadeev, L. B.
    Poltavskaya, M. G.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2024, 20 (06) : 605 - 609
  • [26] Glutamate receptors in pediatric tumors of the central nervous system
    Brocke, Katja S.
    Staufner, Christian
    Luksch, Hella
    Geiger, Kathrin D.
    Stepulak, Andrzej
    Marzahn, Jenny
    Schackert, Gabriele
    Temme, Achim
    Ikonomidou, Chrysanthy
    CANCER BIOLOGY & THERAPY, 2010, 9 (06)
  • [27] Precision medicine for pediatric central nervous system tumors
    Moreira, Daniel C.
    Gajjar, Amar
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (02): : 55 - 57
  • [28] Radiation Therapy for Pediatric Central Nervous System Tumors
    Hoffman, Karen E.
    Yock, Torunn I.
    JOURNAL OF CHILD NEUROLOGY, 2009, 24 (11) : 1387 - 1396
  • [29] Five- Year Survival Rate of Children with Central Nervous System Tumors in Shiraz, Iran
    Zareifar, Soheila
    Rowshani, Fatemeh
    Haghpanah, Sezaneh
    Bordbar, Mohammadreza
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2018, 8 (01) : 1 - 11
  • [30] Facility patient volume and survival among individuals diagnosed with malignant central nervous system tumors
    Johnson, Kimberly J. J.
    Barnes, Justin M. M.
    Delavar, Arash
    O'Connell, Caitlin P. P.
    Wang, Xiaoyan
    JOURNAL OF NEURO-ONCOLOGY, 2023, 161 (01) : 117 - 126